These articles are followed by a contribution from Schiavoni et al. (4) reviewing the major subsets of DC that have been implicated in cross-presentation and the role of type I IFN in enhancing DC-mediated cross-priming of anti-tumor CD8+ T cell responses. The gene discussed is CD8A; the disease is neoplasm.